Indium (111In) altumomabpentetat

Indium ( ¹¹¹ In) altumomabpentetat
Monoklonal antikropp
Typ	Hel antikropp
Källa	Mus
Mål	CEA
Kliniska data
ATC-kod	ingen
Identifierare
CAS-nummer	156586-92-4 ^N
ChemSpider	ingen
UNII	AT2NU9VQ6M
^{N Y} (vad är detta?)

Indium (111In) altumomabpentetat ( INN ) ( USP , indium In 111 altumomabpentetat; handelsnamn Hybri-ceaker ) är en monoklonal musantikropp kopplad till pentetat som fungerar som ett kelatbildande medel för radioisotopen indium-111 . Läkemedlet används för diagnos av kolorektal cancer men har inte godkänts för användning.

Monoklonala antikroppar mot tumörer

Mänsklig	Adecatumumab ^§ Amivantamab Ascrinvacumab ^§ Atezolizumab Balstilimab ^† Botensilimab Cixutumumab ^§ Conatumumab ^§ Daratumumab Drozitumab ^§ Duligotumab ^§ Dusigitumab ^§ Enfortumab vedotin Enoticumab ^§ Figitumumab ^§ Flanvotumab ^§ Ganitumab ^† Glembatumumab vedotin ^† Intetumumab ^§ Ipilimumab Iratumumab ^§ Istiratumab Icrucumab ^§ Lexatumumab ^§ Lucatumumab ^§ Mapatumumab ^§ Narnatumab ^§ Necitumumab Nesvacumab ^§ Nivolumab ^# Ofatumumab Olaratumab ^† Panitumumab Patritumab ^§ Pembrolizumab ^# Pritumumab ^§ Radretumab ^§ Ramucirumab Rilotumumab ^† Robatumumab ^§ Seribantumab ^§ Tarextumab ^§ Tisotumab vedotin Teprotumumab ^† Tovetumab ^§ Vantictumab ^§ Votumumab ^§ Zalutumumab ^†
Mus	Abagovomab Altumomabpentetat Anatumomab mafenatox Arcitumomab Bectumomab Blinatumomab Capromab pendetid Detumomab Edrecolomab Ibritumomab tiuxetan Igovomab Lilotomab Minretumomab Mitumomab Nacolomab tafenatox Moxetumomab pasudotox Naptumomab estafenatox Oregovomab Pemtumomab ^† Rakotumomab Satumomab pendetid Solitomab Taplitumomab paptox Nofetumomab merpentan Pintumomab Tenatumomab Tositumomab
Chimeric	Amatuximab ^§ Bavituximab ^§ Brentuximab vedotin Carotuximab ^† Cetuximab Derlotuximab biotin ^§ Dinutuximab Ekromeximab ^§ Ensituximab ^§ Futuximab ^§ Girentuximab ^† Indatuximab ravtansine ^§ Isatuximab Loncastuximab tesirin Margetuximab Mirvetuximab soravtansin Rituximab ^# Siltuximab Ublituximab
Humaniserad	Abituzumab ^§ Alemtuzumab Belantamab mafodotin Bevacizumab Bivatuzumab mertansin ^§ Brontictuzumab ^§ Cantuzumab mertansin ^§ Cantuzumab ravtansine ^§ Cirmtuzumab Citatuzumab bogatox ^§ Clivatuzumab tetraxetan Cofetuzumab pelidotin Dacetuzumab ^§ Demcizumab ^§ Dalotuzumab ^§ Denintuzumab mafodotin ^§ Elotuzumab Emactuzumab Emibetuzumab ^§ Enoblituzumab ^§ Etaracizumab ^§ Farletuzumab ^§ Ficlatuzumab ^§ Flotetuzumab ^§ Gemtuzumab ozogamicin Imgatuzumab ^§ Inotuzumab ozogamicin Labetuzumab ^§ Lifastuzumab vedotin ^§ Lintuzumab ^§ Lorvotuzumab mertansin ^§ Lumretuzumab ^§ Matuzumab ^§ Milatuzumab ^§ Naxitamab Nimotuzumab ^† Obinutuzumab Ocaratuzumab ^§ Otlertuzumab ^§ Onartuzumab ^§ Opportuzumab monatox ^† Parsatuzumab ^§ Pertuzumab Pinatuzumab vedotin ^§ Polatuzumab vedotin Rosmantuzumab Rovalpituzumab tesirin ^† Sacituzumab govitecan Sibrotuzumab ^§ Simtuzumab ^§ Sofituzumab vedotin ^§ Tacatuzumab tetraxetan ^§ Tigatuzumab ^§ Trastuzumab ^# ( +deruxtekan / +emtansine ) Tucotuzumab celmoleukin ^§ Vandortuzumab vedotin ^§ Vanucizumab ^§ Veltuzumab ^§ Vorsetuzumab mafodotin ^§ PankoMab
Råtta/mus hybrid	Catumaxomab Ertumaxomab ^§
Chimär + humaniserad	Depatuxizumab mafodotin ^† Duvortuxizumab Ontuxizumab ^§

^# VEM-EM
^‡ Dras tillbaka från marknaden
Kliniska prövningar :
- ^† Fas III
- ^§ Aldrig till fas III

Kategorier:

Hämtad från " https://en.wikipedia.org/w/index.php?title=Indium_(111In)_altumomab_pentetate&oldid=1088333823 "